QL-1706
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QL-1706, covering 2025-01-07 to 2025-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy [Phase 1]